Press release - 25/11/2025 CELLnROLL receives funding from EXIST Research Transfer CELLnROLL is a spin-off from the Max Planck Institute for Intelligent Systems. The newly founded company develops a high-precision microrobotic-based cell sorting system to help clinicians make fast, affordable, and informed decisions for cancer diagnostics. Now, the project has received €865,000 in funding through the EXIST Transfer of Research program, a funding program initiated by the German Federal Ministry for Economic Affairs and Energy. https://www.gesundheitsindustrie-bw.de/en/article/press-release/cellnroll-receives-funding-exist-research-transfer
Press release - 21/11/2025 How mitochondria influence mental health Hans Kupczyk visiting professorship for Professor Martin Picard He researches stress and ageing at the interface of psychology and biology and is a guest at Ulm University: Professor Martin Picard from Columbia University has been awarded the Hans Kupczyk Visiting Professorship 2025, which is based in the Department of Clinical and Biological Psychology this year. On the occasion of the awarding of the visiting professorship, Picard spoke about energy as the foundation of human health of body and mind.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-mitochondria-influence-mental-health-hans-kupczyk-visiting-professorship-professor-martin-picard
Press release - 17/11/2025 How painkillers can contribute to anemia in cancer patients Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-painkillers-can-contribute-anemia-cancer-patients
Press release - 13/11/2025 New Initiative: Light for Public Health Light affects how we sleep, feel, and perform – yet public awareness of its impact remains limited. The Light for Public Health initiative aims to make evidence-based knowledge on light and health both accessible and actionable, thus turning scientific insight into public benefit.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-initiative-light-public-health
Press release - 10/11/2025 How the heart maintains its shape and function – and what can go wrong A team from the DZHK sites in Heidelberg/Mannheim and Berlin has discovered that a single enzyme in the heart plays a key role in determining whether the organ develops in a healthy manner. If this molecular protective factor is missing, serious congenital heart defects can develop.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-heart-maintains-its-shape-and-function-and-what-can-go-wrong
Press release - 07/11/2025 How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves Endometriosis, menopause, ovarian cancer – still poorly researched and often misdiagnosed. Ângela Gonçalves combines AI, molecular biology, and clinical findings to develop non-invasive tools for early detection, personalized care, and healthier aging. The scientist from the DKFZ-Hector Cancer Institute is the winner of the Falling Walls Foundation's “Breakthrough of the Year 2025” award in the Women's Impact category.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biological-clock-ticks-female-reproductive-tract-breakthrough-year-award-2025-angela-goncalves
Press release - 07/11/2025 Overcoming Tumor Resistance to Immunotherapy: The European Research Council awards international project led by Heidelberg Medical Faculty In the PRECISION-ImmunoRad project, a multidisciplinary team of scientists from Heidelberg, USA, and Cyprus will unite their expertise to develop novel curative therapeutic strategies for currently hard-to-treat cancers. These strategies will integrate high-precision ion beam therapy with genetically engineered immune cells therapies (CAR-T cells), personalized cancer vaccines, and the targeted reprogramming of the tumor immune microenvironment. https://www.gesundheitsindustrie-bw.de/en/article/press-release/overcoming-tumor-resistance-immunotherapy-european-research-council-awards-international-project-led-heidelberg-medical-faculty
Artificial intelligence: opportunities for healthcare - 06/11/2025 More than just deskwork: opportunities and obstacles for generative AI in healthcare Generative artificial intelligence (GenAI) has enormous potential in healthcare, ranging from automating time-consuming deskwork to supporting diagnoses. It is not just for the big players; there are also cost-effective ways for smaller companies and institutions to utilize GenAI.https://www.gesundheitsindustrie-bw.de/en/article/news/more-just-deskwork-opportunities-and-obstacles-generative-ai-healthcare
Press release - 05/11/2025 Novel Technique Improves Brain-State Detection Researchers have developed a new method that greatly improves the accuracy of brain-state classification with functional near-infrared spectroscopy (fNIRS). The brain-imaging technique fNIRS allows researchers to measure neural activity: Active brain cells need more oxygen, so variations in blood flow and oxygen saturation indicate which brain regions are at work. fNIRS detects these changes safely and without invasive procedures.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-technique-improves-brain-state-detection
Press release - 04/11/2025 Brain Tumor Charity supports immunotherapy for childhood brain tumors with 1.5 million pounds sterling Ependymomas, brain tumors that occur particularly in young children, are especially difficult to treat and more than half of the children affected have an increased risk of relapse. As part of an international consortium, the KiTZ, the DKFZ, the MFHD and UKHD have received a grant of 1.5 million pounds sterling (GBP) from the British organization The Brain Tumor Charity to develop a new type of immunotherapy for ependymoma.https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-tumor-charity-supports-immunotherapy-childhood-brain-tumors-15-million-pounds-sterling
Press release - 28/10/2025 AI solutions from the DKFZ set new standards in medical image processing Researchers at the German Cancer Research Center (DKFZ) have achieved outstanding success at this year's world-leading forum for medical image processing and computer-assisted intervention. Two DKFZ departments competed in eight international AI competitions – and won seven of them. The successes cover key areas of oncology – from early detection and diagnosis to therapy support and follow-up care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-solutions-dkfz-set-new-standards-medical-image-processing
Press release - 27/10/2025 Role of intestinal bacteria in the development of colorectal cancer: Emmy Noether grant for DKFZ researcher Jens Puschhof The German Research Foundation (DFG) is funding a new Emmy Noether project led by Jens Puschhof from the German Cancer Research Center (DKFZ). With this project, the junior researcher aims to decipher the role of certain intestinal bacteria in the earliest stages of colorectal cancer development and investigate how this process can be halted. The long-term goal is to develop new preventive strategies against colorectal cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/role-intestinal-bacteria-development-colorectal-cancer-emmy-noether-grant-dkfz-researcher-jens-puschhof
Press release - 27/10/2025 OnkoAktiv receives Cancer Innovation Award 2025 The nationwide OnkoAktiv network, founded at the National Center for Tumor Diseases (NCT) in Heidelberg, has been awarded the Baden-Württemberg Cancer Innovation Prize 2025. The prize recognizes OnkoAktiv for its pioneering role and groundbreaking contribution to the integration of exercise into oncological care.https://www.gesundheitsindustrie-bw.de/en/article/press-release/onkoaktiv-receives-cancer-innovation-award-2025
Press release - 16/10/2025 Sleep as the key to understanding ME/CFS The Federal Ministry of Research, Technology and Space (BMFTR) is supporting the “Sleep-Neuro-Path” research network with around 1.6 million euros. Coordinated by the Central Institute of Mental Health (CIMH) in Mannheim, a team of scientists is investigating the role of sleep-related biomarkers in the development of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleep-key-understanding-mecfs
Press release - 15/10/2025 NGS-based diagnostics for identifying sepsis pathogens wins EARTO Innovation Award A method developed at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB enables bacterial, viral, fungal, or parasitic pathogens in sepsis patients to be identified much faster than before and with the highest precision. The approach is based on high-throughput sequencing of cell-free DNA circulating in the blood and was honored with the EARTO Innovation Award in the "Impact Delivered" category on October 14,…https://www.gesundheitsindustrie-bw.de/en/article/press-release/ngs-based-diagnostics-identifying-sepsis-pathogens-wins-earto-innovation-award
Press release - 09/10/2025 Transparent artificial intelligence improves assessment of prostate cancer aggressiveness Until today, the aggressiveness of prostate cancer has been assessed primarily using the Gleason grading system—an analysis of cancer tissue in a pathology laboratory that is highly subjective. An international research team led by the German Cancer Research Center (DKFZ) has now developed a novel, explainable AI model that aims to make the diagnosis of prostate cancer more transparent and less susceptible to error.https://www.gesundheitsindustrie-bw.de/en/article/press-release/transparent-artificial-intelligence-improves-assessment-prostate-cancer-aggressiveness
Press release - 06/10/2025 3D imaging points to possible cause of sudden cardiac death An imaging technique developed by Freiburg researchers provides insights into cardiac arrhythmias that can cause sudden cardiac death in animal models. The changes discovered could explain why even seemingly healthy people are sometimes affected.https://www.gesundheitsindustrie-bw.de/en/article/press-release/3d-imaging-points-possible-cause-sudden-cardiac-death
Medical image analysis - 25/09/2025 Powerful AI systems using synthetic training data AI systems for image analysis are only as good as the data on which they are trained. The Göppingen-based start-up MIRA Vision has developed a novel method for generating synthetic, photorealistic images, enabling the efficient creation of large, high-quality training datasets. An intuitive platform also allows researchers to evaluate microscopy images with ease.https://www.gesundheitsindustrie-bw.de/en/article/news/powerful-ai-systems-image-analysis-using-synthetic-training-data
Press release - 12/09/2025 In bad company: Immune cells in the tumor environment determine the success of therapy for childhood brain tumors The cellular environment of a tumor can either support or sabotage recovery. The most comprehensive study to date on the tumor microenvironment in low-grade gliomas, conducted by KiTZ, Jena University Hospital, the DKFZ, and Heidelberg University Hospital, shows what a supportive or obstructive “neighborhood” looks like in childhood brain tumors. The study also provides clues as to how tumor communication might be blocked. https://www.gesundheitsindustrie-bw.de/en/article/press-release/bad-company-immune-cells-tumor-environment-determine-success-therapy-childhood-brain-tumors
Fluorescence and smartphones instead of laboratories - 11/09/2025 Mobile blood-analysis system for at home medication monitoring For many medications, regular monitoring of drug concentrations in the blood is necessary to ensure efficacy and safety. Until now, this process has been time-consuming and required laboratory personnel and resources. The Heidelberg based start up QuantiLight has developed a mobile device with innovative sensor technology that enables quick, easy measurements at home or in a doctor's surgery.https://www.gesundheitsindustrie-bw.de/en/article/news/mobile-blood-analysis-system-home-medication-monitoring
Press release - 08/09/2025 New and simple detection method for nanoplastics A joint team from the University of Stuttgart in Germany and the University of Melbourne in Australia has developed a new method for the straightforward analysis of tiny nanoplastic particles in environmental samples. One needs only an ordinary optical microscope and a newly developed test strip—the optical sieve. The research results have now been published in “Nature Photonicshttps://www.gesundheitsindustrie-bw.de/en/article/press-release/new-and-simple-detection-method-nanoplastics
Press release - 04/09/2025 Fraunhofer researchers develop innovative diagnostics for detecting antibiotic resistance in bacterial infections The rapid increase in antibiotic-resistant bacteria is one of the most pressing challenges facing global health. A new transatlantic Fraunhofer research project aims to counter these threats with an innovative diagnostic approach: a microfluidic rapid test system using carbon nanotubes (SWCNT) will make bacterial resistance visible in just a few minutes, significantly faster than conventional methods.https://www.gesundheitsindustrie-bw.de/en/article/press-release/fraunhofer-researchers-develop-innovative-diagnostics-detecting-antibiotic-resistance-bacterial-infections
Enhancing human perception of the imperceptible - 28/08/2025 AI-driven imaging expands possibilities in surgery Doctors frequently experience a restricted view of the surgical field, particularly during endoscopic procedures. A novel technique developed by Prof. Dr. Lena Maier-Hein's team at the DKFZ in Heidelberg integrates spectral imaging with AI-driven data analysis. This innovation facilitates accurate tissue differentiation and delivers real-time insights into organ function.https://www.gesundheitsindustrie-bw.de/en/article/news/ai-driven-imaging-expands-possibilities-surgery
Press release - 26/08/2025 Key mechanism for Alzheimer's disease discovered A molecular mechanism that contributes to the progression of Alzheimer’s disease has been discovered by a research team of Heidelberg University. The team, using an Alzheimer’s mouse model, demonstrated that a neurotoxic protein-protein complex is responsible for nerve cells in the brain dying off and the resulting cognitive decline. This finding opens up new perspectives for the development of effective treatments.https://www.gesundheitsindustrie-bw.de/en/article/press-release/key-mechanism-alzheimers-disease-discovered
Press release - 14/08/2025 Speeding up long-term memory Svenja Brodt uses MRI brain scans to investigate how impressions become memories. A better understanding of how long-term memories are formed could help Alzheimer's patients cope with their daily lives. Impaired memory formation could be compensated for by targeted repetition.https://www.gesundheitsindustrie-bw.de/en/article/press-release/speeding-long-term-memory
Press release - 12/08/2025 Biomarkers for Brain Insulin Resistance Discovered in the Blood If the brain no longer responds properly to insulin (insulin resistance), this can lead to overweight, diabetes, and Alzheimer's disease. Researchers at the DZD in Potsdam and Tübingen have discovered small chemical modifications to genetic material (epigenetic changes*) in the blood that indicate how well the brain responds to insulin. These markers could help to detect insulin resistance in the brain – by means of a simple blood test.https://www.gesundheitsindustrie-bw.de/en/article/press-release/biomarkers-brain-insulin-resistance-discovered-blood
Press release - 04/08/2025 FOXP1 syndrome: Potential therapeutic approach discovered for rare language development disorder FOXP1 syndrome is a congenital disorder in which the brain development of affected children is severely impaired due to a genetic variant. A research team from the Medical Faculty Heidelberg at Heidelberg University has now demonstrated in mice, that the inhibition of a specific enzyme in the brain can improve abnormal behavior and immune cell dysfunction in the brain. The results have been published in the journal Advanced Science.https://www.gesundheitsindustrie-bw.de/en/article/press-release/foxp1-syndrome-potential-therapeutic-approach-discovered-rare-language-development-disorder
Press release - 01/08/2025 Early Pancreatic Cancer Detection Tumors of the pancreas seldom cause symptoms in their early stages. This means that in many cases, they are not diagnosed until late, when the chances of successful treatment are poor. A new non-invasive diagnostic method designed by Fraunhofer researchers is set to make it possible to detect this aggressive form of cancer early on with high accuracy, significantly improving the prognosis for treatment.https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-pancreatic-cancer-detection
Press release - 01/08/2025 A Less Debilitating Approach to Cancer Diagnosis Less radiation exposure during diagnosis and treatment for breast and lung cancer: New Fraunhofer method combines X-ray imaging and radar. In the MultiMed project, which explores multimodal medical imaging in 3D, researchers are developing a method that combines X-ray imaging and radar. It´s not only expected to improve the accuracy and efficacy of diagnosing, monitoring and treating breast and lung cancer but also lighten the burden on patients.https://www.gesundheitsindustrie-bw.de/en/article/press-release/less-debilitating-approach-cancer-diagnosis
Breath test replaces invasive diagnostics - 30/07/2025 Novel smartphone sensor offers innovative breath test to detect Helicobacter infection The stomach bacterium Helicobacter pylori is widespread and, if left undetected, can impact our well-being and also lead to serious health conditions. While effective treatments exist, a reliable diagnosis is essential. To address this, researchers have developed an affordable breath test that uses a mini-sensor to detect the presence of the bacterium. They are currently working on a smartphone-compatible version for self-testing.https://www.gesundheitsindustrie-bw.de/en/article/news/novel-smartphone-sensor-offers-innovative-breath-test-detect-helicobacter-infection
Press release - 29/07/2025 New method to design custom protein binder Designing protein binders from scratch has long been a daunting challenge within the field of computational biology. Researchers have now developed an innovative, training-free pipeline that uses the fundamental principle of shape complementarity to design site-specific protein binders, which are then optimised to fit precisely onto chosen target sites. The researchers tested this on proteins linked to cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-method-design-custom-protein-binder
Press release - 24/07/2025 The origin of evil: stem cell-like cells are the reason for relapses of blood cancer in children and adolescents Stem cell-like leukemia cells are responsible for relapses in children and adolescents with a certain type of blood cancer, T-ALL. Researchers at the Hopp Children's Cancer Center Heidelberg (KiTZ), the Molecular Medicine Partnership Unit and the German Cancer Research Center were able to show this in a study. The results could help to overcome resistance in this form of blood cancer and prevent relapses.https://www.gesundheitsindustrie-bw.de/en/article/press-release/origin-evil-stem-cell-cells-are-reason-relapses-blood-cancer-children-and-adolescents
Press release - 24/07/2025 What makes cells migrate – and what can stop them Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body - not only during normal tissue formation and wound healing, but also when tumor cells metastasize. This makes the enzyme an interesting candidate for potential future therapeutic approaches.https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-makes-cells-migrate-and-what-can-stop-them
Press release - 22/07/2025 Colorectal cancer in type 2 diabetes: An insightful look into the microenvironment of tumors Diabetics have a higher risk of colorectal cancer and often a poorer prognosis after developing the disease. The biological mechanisms behind this association were largely unknown. A research team at the German Cancer Research Center (DKFZ) has now discovered that tumors with a low number of immune cells appear to be particularly susceptible to the harmful effects of diabetes. https://www.gesundheitsindustrie-bw.de/en/article/press-release/colorectal-cancer-type-2-diabetes-insightful-look-microenvironment-tumors
Press release - 18/07/2025 Faster sepsis diagnosis through hyperspectral imaging and AI Sepsis is one of the most dangerous medical emergencies. The condition is the result of a misdirected immune response to an infection, which can quickly lead to organ failure and death. Every hour counts – but early detection is difficult. A new study from Heidelberg now presents an innovative approach: artificial intelligence (AI) and hyperspectral imaging of the skin enable immediate and non-invasive sepsis diagnosis directly at the bedside.https://www.gesundheitsindustrie-bw.de/en/article/press-release/faster-sepsis-diagnosis-through-hyperspectral-imaging-and-ai
AI-supported image recognition accelerates identification of zebrafish mutants - 16/07/2025 EmbryoNet AI automatically identifies developmental disorders In complex organisms, embryonic development is tightly regulated by intricate signalling pathways. When these pathways are disrupted, they can lead to characteristic developmental defects that are not easy to detect with the naked eye. Developmental biologist Prof. Dr. Patrick Müller from the University of Konstanz has developed EmbryoNet, an AI-powered software tool that uses image analysis to reliably identify such developmental disorders.https://www.gesundheitsindustrie-bw.de/en/article/news/embryonet-ai-automatically-identifies-developmental-disorders
Press release - 08/07/2025 Five million euros for research into early cancer detection Investing in a healthier future: The HORNBACH Group is supporting the new National Cancer Prevention Center in Heidelberg with a donation of five million euros. In the future, a new laboratory will conduct research into more effective early detection and screening methods.https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-million-euros-research-early-cancer-detection
Press release - 03/07/2025 Focus on Muscle Metabolism: Sex Differences in Sport and Obesity The skeletal muscles of men and women process glucose and fats in different ways. A study provides the first comprehensive molecular analysis of these differences. The results possibly give an explanation why metabolic diseases such as diabetes manifest differently in women and men – and why they respond differently to physical activity. https://www.gesundheitsindustrie-bw.de/en/article/press-release/focus-muscle-metabolism-sex-differences-sport-and-obesity
Press release - 27/06/2025 Felix Glang receives Otto Hahn Medal Felix Glang, of the Max Planck Institute for Biological Cybernetics in Tübingen, has been awarded the Otto Hahn Medal in recognition of his achievements in developing new magnetic resonance imaging (MRI) methods. Glang's methods enable clearer and faster brain scans.https://www.gesundheitsindustrie-bw.de/en/article/press-release/felix-glang-receives-otto-hahn-medal
Press release - 18/06/2025 Hector Foundation Prize 2025 for Annika Reinke: “Metrics Reloaded” improves the quality of AI-supported image analysis Computer scientist Annika Reinke from the German Cancer Research Center (DKFZ) has been awarded the Hector Foundation Prize 2025, endowed with €10,000, for her outstanding work in the field of AI-supported medical image analysis. She received the award for the project Metrics Reloaded, which can significantly improve the quality and reliability of AI-supported image analysis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hector-foundation-prize-2025-annika-reinke-metrics-reloaded-improves-quality-ai-supported-image-analysis
Diagnostic tool for people with Crohn's disease and ulcerative colitis - 17/06/2025 Chronic inflammatory bowel disease - using an app to sustainably improve everyday life Keeping appointments? Planning everyday life? For people living with chronic inflammatory bowel disease (IBD), sudden and unpredictable flare-ups can severely limit their ability to participate in daily life. The start-up coreway aims to improve the quality of life for individuals affected by IBD by leveraging data-driven insights and contributing to the advancement of personalised medicine.https://www.gesundheitsindustrie-bw.de/en/article/news/chronic-inflammatory-bowel-disease-using-app-sustainably-improve-everyday-life
Press release - 16/06/2025 Novel laboratory models pave the way for targeted therapies for childhood sarcomas Sarcomas in soft tissue usually occur in young people and are difficult to treat. Due to a lack of laboratory models, the causes of their development are poorly understood. A team of researchers has now succeeded in creating mouse models with a functioning immune system that replicate sarcoma types that remain unstudied. The method opens up new avenues for the targeted development of immunotherapies for children and adolescents with sarcomas.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-laboratory-models-pave-way-targeted-therapies-childhood-sarcomas
Press release - 11/06/2025 Antiviral tests on protective clothing for infection control Textiles functionalized with antiviral agents are intended to reduce the risk of transmission of pathogens, particularly in a medical environment. These antiviral properties must be carefully tested and verified in laboratory tests. The biological testing laboratory of the German Institutes of Textile and Fiber Research Denkendorf has examined antiviral activities with coronaviruses as part of a research project on textiles for infection control.https://www.gesundheitsindustrie-bw.de/en/article/press-release/antiviral-tests-protective-clothing-infection-control
Press release - 05/06/2025 Colorectal cancer screening via smartphone? Colorectal cancer screening programs are currently underutilized in Germany. This also applies to testing for blood in the stool. The immunological stool tests can detect tiny amounts of blood in the stool. Scientists at the German Cancer Research Center (DKFZ) have investigated whether smartphone-based testing could be a meaningful alternative or supplement to traditional laboratory tests.https://www.gesundheitsindustrie-bw.de/en/article/press-release/colorectal-cancer-screening-smartphone
Press release - 26/05/2025 Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators.https://www.gesundheitsindustrie-bw.de/en/article/press-release/explainable-artificial-intelligence-increases-accuracy-and-endurance-dermatologists-melanoma-diagnosis
Press release - 22/05/2025 Six Clusters of Excellence for the University of Tübingen Tübingen achieves remarkable success and has good chance of maintaining its University of Excellence title – Top research in three areas to be sustained from other sources of support.https://www.gesundheitsindustrie-bw.de/en/article/press-release/six-clusters-excellence-university-tubingen
Press release - 12/05/2025 NMI expertise for new VDI guideline on bioprinting - now available VDI Guideline 5708 “Bioprinting, methods and definitions”: What sounds technical and sober at first glance is an important step forward in the future field of 3D bioprinting. The guideline was developed under Dr. Hanna Hartmann from the NMI in Reutlingen and Prof. Dr. Jürgen Groll from the University Hospital of Würzburg. It creates a binding, practical basis for reproducible and quality-assured bioprinting procedures.https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmi-expertise-new-vdi-guideline-bioprinting-now-available
Press release - 08/05/2025 Childhood brain tumors develop early in highly specialized nerve cells Medulloblastomas, childhood brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of life. Researchers have now published their findings in the journal Nature. They analyzed the genetic changes of each individual cancer cell in tumor samples in order to reconstruct which genetic changes occur first during tumor development and when.https://www.gesundheitsindustrie-bw.de/en/article/press-release/childhood-brain-tumors-develop-early-highly-specialized-nerve-cells
Press release - 07/05/2025 Contactless. Precise. Pioneering: Muscle Monitoring with Quantum Sensors A research team led by PD Dr. Justus Marquet and from the Hertie Institute for Clinical Brain Research has developed two methods that allow muscle activity and training-induced adaptations to be measured completely contactlessly. The studies demonstrate that magnetic fields generated during muscle activity can be captured using highly sensitive quantum sensors - without the need for electrodes or skin contact.https://www.gesundheitsindustrie-bw.de/en/article/press-release/contactless-precise-pioneering-muscle-monitoring-quantum-sensors
Press release - 16/04/2025 Hereditary Alzheimer’s: Blood Marker for Defective Neuronal Connections Rises Early Individuals with a genetic predisposition to Alzheimer’s disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms. This is evident in the levels of the protein “beta-synuclein”. An international team report these findings in the journal “Alzheimer’s & Dementia”. The biomarker studied here could potentially help to detect neurodegeneration at an early stage.https://www.gesundheitsindustrie-bw.de/en/article/press-release/hereditary-alzheimers-blood-marker-defective-neuronal-connections-rises-early